CAMBRIDGE, UNITED KINGDOM--(Marketwire - March 06, 2008) - BioWisdom Ltd (BioWisdom), a bazaar baton in carrying healthcare intelligence to the biologic industry, today appear that Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) has continued its Collaboration Agreement with OmniViz, Inc., extending J&JPRD´s authorization rights to OmniViz software for advice decision and abstracts mining.
"We are captivated with J&JPRD´s accommodation to abide its accord with OmniViz" said Michael Stapleton, BioWisdom´s CBO. "As our investment in the conception of absolutely aesthetics powered applications like OmniViz grows, so does the accent of our cardinal collaborators with absolute apple use cases and validation."
OmniViz beheld intelligence software is a complete band-aid for all abstracts visualization, abnormally acknowledging the appraisal of text, numeric and absolute information.
Notes to Editors
ABOUT BIOWISDOM
BioWisdom delivers intelligence for the Healthcare Industry and helps audience to cross the circuitous accurate and bartering issues complex in developing acknowledged healthcare products. The aggregation provides a able apartment of software accoutrement for the formatting, search, decision and top amount appraisal of healthcare intelligence. The BioWisdom aggregation combines all-encompassing acquaintance of the biologic and biotechnology industries with accurate ability in activity science software development.
Contacts:
BioWisdom Ltd
Gordon Baxter
CEO
+44 (0)1223 874800
BioWisdom Ltd
Julie Barnes
CSO
+44 (0)1223 874800
BioWisdom Ltd
Jason Marth
Director of Sales
+44 (0)1223 874800
Email: info@biowisdom.com
Website: www.biowisdom.com
The Hogarth Partnership
Melanie Toyne-Sewell
+44 (0)207 357 9477
Email: mtoyne-sewell@hogarthpr.co.uk
The Hogarth Partnership
Sarah Richardson
+44 (0)207 357 9477
Email: srichardson@hogarthpr.co.uk
The advertisement was broadcast by Hugin.
The issuer is alone amenable for the agreeable of this announcement.
订阅：
博文评论 (Atom)
没有评论:
发表评论